Patients who lose fat while gaining muscle through exercise may see modest scale changes while experiencing dramatic visual transformation
When you come off the drug, the weight comes back on, a phenomenon dubbed the Ozempic rebound
If your insurance doesnt cover it or youre paying out of pocket, talk to your doctor about alternatives to Ozempic, Wegovy, and Rybelsus
Tirzepatide is a dual agonist, working on both GLP-1 and GIP receptors, which produces larger average weight loss in head-to-head trials
Tirzepatide (Dual Receptor) Mounjaro FDA-approved for type 2 diabetes Zepbound FDA-approved for obesity Tirzepatide activates two receptors: GLP-1 and GIP
After 5 days, skip the dose and continue on your normal schedule